Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
AKAMAI V – “How To” Induce Infringement of a Method of Treatment Claim
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Are Patent-Friendly PTAB Decisions On the Rise?
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)
USPTO Applicants face dismal odds in finance-related arts, but odds good outside the US
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
PTAB Dismisses Three IPR Petitions Based on Sovereign Immunity
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Transubstantiation of a Machine into an Abstract Idea
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Chisum Academy Awards for 2016 to Federal Circuit Decisions
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Guidance on Biosimilar Development Finalized by FDA
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
In re NuVasive, Inc. – Explain Yourself!
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
USPTO Holds First Roundtable on “Subject Matter Eligibility Guidelines”
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
PTO Schedules s. 101 Roundtables
Blog
![SLWI Banner10](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner10-305x180.jpg)
Board Declines to Resolve Real Party In Interest Dispute
Blog
![SLWI Banner4](https://www.slwip.com/wp-content/uploads/2016/05/SLWI-Banner4-1-305x180.jpg)